Select a Session
Choose a preset or operator-defined program based on the intended wellness or recovery objective.
PROJECT RESONANCE™ · EF RESONATOR · WHOLE-BODY PEMF
The EF Resonator is a programmable whole-body electromagnetic wellness and research platform — built around documented output, repeatable protocols, careful claims, and a clear path from prototype to pilot deployment.
01 · THE PLATFORM
The EF Resonator integrates three layers in one configurable platform: a whole-body coil bed, a programmable control system, and a research-ready data layer — with real-time monitoring and safety systems throughout.
02 · THE EXPERIENCE
A clean, guided experience built around comfort, consistency, and repeatable operation.
Choose a preset or operator-defined program based on the intended wellness or recovery objective.
The user lies comfortably on the padded platform while the system performs status and safety checks.
The controller delivers the programmed PEMF session while timing and system conditions are monitored.
Usage data and session history can support consistent operating protocols and future software development.
03 · DESIGNED FOR MODERN WELLNESS
Initial markets follow where premium wellness is already purchased: longevity, chiropractic, physical-therapy and sports-recovery clinics; premium gyms, recovery centers and professional teams; and universities and investigators who need configurable field delivery.
PERFORMANCE
ACTIVE LIFESTYLE
WORKFORCE
04 · CORE SYSTEM FEATURES
Programmable output architecture intended to support validated protocol development.
Operator-friendly interface for session setup — proposed 5–60 minute programs with countdown, pause, and controlled stop.
Designed around measurable electromagnetic output rather than frequency alone.
Coil and electronics monitoring with automatic fault handling and shutdown logic.
Emergency controls, current limits, electrical isolation, and operating safeguards.
Fifteen named preset slots, protocol libraries, diagnostics, session logging, and future cloud features.
05 · FOR BUSINESS
Project Resonance is positioned for wellness centers, athletic recovery facilities, clinics operating within applicable regulations, corporate recovery programs, research partners, and multi-location operators.
Preliminary model — customer discovery will determine the best mix of ownership, leasing, and recurring revenue. Full planning documents are in the investor dataroom.
Business & Investor InquirySERIES A · AUGUST 2026
Proposed allocation; final budget follows engineering quotations and regulatory counsel. Pricing, adoption, margins, and timing must be validated through prototype and customer discovery.
06 · DEVELOPMENT ROADMAP
Engineering and validation first — commercial expansion follows measurable readiness gates, with capital released only against verified deliverables.
Requirements, simulation, risk analysis, alpha prototype, and supplier plan.
Beta units, safety and usability testing, design iteration, and the regulatory decision.
Limited production, reference sites, service model, and the commercial-readiness decision.
The commercial ramp follows the same discipline: 5–10 pilot sites, then 20–30 reference sites, then channel growth through clinic groups, distributors, and research partners.
07 · EVIDENCE
Published PEMF research reports mixed, protocol-dependent results — and existing literature does not establish that any new platform is safe or effective for a specific condition. So no claim gets ahead of device-specific evidence: every session is measurable, logged, and repeatable, and validation proceeds in order.
Field mapping, electrical safety, thermal behavior, repeatability, and EMC.
Training, contraindications, labeling, workflow, and adverse-event capture.
Prospective protocols designed with independent investigators and regulatory counsel.
Launch conservatively; expand with evidence — general wellness positioning first, research partnerships second, and specific indications pursued only with evidence and the appropriate FDA pathway.
08 · THE VISION
The mission is straightforward: build a premium, credible, measurable whole-body PEMF platform that feels as advanced as the technology inside it.
Founder Robert Merrill is an experienced entrepreneur and former chief executive who founded and operated approximately fifteen companies with a combined workforce of about 3,000 employees — spanning logging, sawmill operations, commercial fishing, and heavy equipment. He brings that operating discipline to Project Resonance, supported by a planned advisory bench across electromagnetics engineering, independent science, regulatory and quality, and manufacturing, appointed as the program scales.
“Build it right. Validate it. Make it simple to use. Then scale it.”
ROBERT MERRILL · FOUNDER & OWNER · PROJECT RESONANCE™
09 · PROJECT VISION
Concept and vision boards — product renderings and program details are illustrative and subject to engineering validation.
10 · COMMON QUESTIONS
Project Resonance is a whole-body programmable PEMF platform concept designed around controllable electromagnetic fields, a treatment bed, large coil assemblies, electronic monitoring, and a modern commercial user experience.
No. The website presents Project Resonance as a wellness and technology platform. It is not intended to replace diagnosis, treatment, or medical care. Any medical-device claims or indications would require appropriate testing, evidence, and regulatory authorization.
The commercial vision includes wellness centers, performance and recovery facilities, research environments, fitness operators, and other organizations that can use the system within applicable laws and professional standards.
Published PEMF studies report potentially useful signals in selected musculoskeletal contexts, but results vary by device, protocol, and study quality — and existing literature does not establish that the EF Resonator is safe or effective for any condition. The development program treats that honestly: bench characterization, human-factors work, and independent studies come before any claim.
Project Resonance is raising a $15M Series A (August 2026), released in stages against verified technical milestones, to reach prototype, validation, and pilot readiness over approximately 30 months. The full planning documents — pitch deck, budgets, engineering specification, regulatory memo, and evidence review — are available in the investor dataroom.
Yes. Use the contact form below for product, partnership, investor, distribution, or facility inquiries.
REQUEST INFORMATION
Tell us whether you are interested in ownership, partnerships, investment, research, distribution, or a future demonstration.